These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10449515)

  • 1. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs).
    Shiff SJ; Rigas B
    J Exp Med; 1999 Aug; 190(4):445-50. PubMed ID: 10449515
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.
    Zhang X; Morham SG; Langenbach R; Young DA
    J Exp Med; 1999 Aug; 190(4):451-59. PubMed ID: 10449516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS; Rao CV
    J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of arachidonic acid regulatory enzymes in colorectal disease.
    Abir F; Alva S; Kaminski DL; Longo WE
    Dis Colon Rectum; 2005 Jul; 48(7):1471-83. PubMed ID: 15868226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer.
    Marnett LJ
    Prev Med; 1995 Mar; 24(2):103-6. PubMed ID: 7597006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-independent actions of cyclooxygenase inhibitors.
    Tegeder I; Pfeilschifter J; Geisslinger G
    FASEB J; 2001 Oct; 15(12):2057-72. PubMed ID: 11641233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin decreases arachidonic acid uptake in HCA-7 human colon cancer cells.
    Orido T; Fujino H; Hasegawa Y; Toyomura K; Kawashima T; Murayama T
    J Pharmacol Sci; 2008 Nov; 108(3):389-92. PubMed ID: 18987430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type-specific activation of c-Jun N-terminal kinase by salicylates.
    Schwenger P; Alpert D; Skolnik EY; Vilcek J
    J Cell Physiol; 1999 Apr; 179(1):109-14. PubMed ID: 10082138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia].
    Di Girolamo G; Franchi A; De Los Santos AR; Martí ML; Farina M; Fernández de Gimeno MA
    Medicina (B Aires); 2001; 61(5 Pt 1):566-72. PubMed ID: 11721323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding.
    Lee I; Cryer B
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):597-612. PubMed ID: 21944413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
    Kashfi K; Rigas B
    Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying suppression of lymphocyte responses by nonsteroidal antiinflammatory drugs.
    Rossi Paccani S; Boncristiano M; Baldari CT
    Cell Mol Life Sci; 2003 Jun; 60(6):1071-83. PubMed ID: 12861376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-steroidal anti-inflammatory agents and cyclooxygenases].
    Vergne P; Bertin P; Bonnet C; Rigaud M; Treves R
    Therapie; 1996; 51(6):639-46. PubMed ID: 9164000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.